Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Elche
Clinical trial register · Spain

Clinical Trials in Elche, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Spain and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5875 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:18 UTC
5875
Studies in scope
all four open statuses
3096
Recruiting now
open to new participants
1137
Lead sponsors
across recruiting studies
Top sites
Barcelona 3238 Madrid 3046 Valencia 1215 Seville 1054 Málaga 746
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Pfizer7 Universidad Miguel Hernandez de Elche6 Hoffmann-La Roche5 Fundación GECP4 Novartis Pharmaceuticals4
Site location
Barcelona3238 Madrid3046 Valencia1215 Seville1054 Málaga746
All 453 locations
Target enrolment
to

Trials with a site in Elche

111 of 5875 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Spain
Start
Recruiting
University of Alicante
Not applicable
120
Elche
2026-11-01
Not yet open
Universidad Miguel Hernandez de Elche
Not applicable
236
Elche
2026-10
Not yet open
Fundación GECP
Phase 2
68
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Granada, Santiago de Compostela, Lugo
2026-09-15
Recruiting
CSL Behring
Phase 3
63
Elche, Barcelona, Badalona, Santander, Madrid
2026-09-15
Recruiting
Kenko Imalytics S.L.
Observational
200
Elche
2026-07-22
Recruiting
Mindfulness-Based Cognitive Therapy (MBCT) for the Prevention of Depression Relapse or Recurrence Using Videoconference
NCT06832605Major Depressive Disorder, Recurrent, in Remission, Major Depressive Disorder, Recurrent, Mild, Major Depressive Disorder, Recurrent, Moderate
Fundació Sant Joan de Déu
Not applicable
342
Elche, Barcelona, Sant Boi de Llobregat, Zaragoza
2026-06-10
Recruiting
Study of Tarlatamab as Maintenance Treatment After Chemo-radiotherapy for Limited Stage SCLC Patients
NCT07242547Limited-stage Small-cell Lung Cancer, Carcinoma, Small Cell Lung, Respiratory Tract Neoplasms, Thoracic Neoplasms
DrugTarlatamab
Fundación GECP
Phase 2
37
Albacete, Alicante, Elche, Barcelona, Manresa, Bilbao, Jerez de la Frontera, Lugo
2026-05-20
Recruiting
Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
NCT07611747Rheumatoid Arthritis (RA), Psoriatic Arthritis (PsA), Axial Spondy, Systemic Lupus Erythematosus (SLE)
Instituto de Investigación Marqués de Valdecilla
Phase 4
1,944
Alicante, Elche, Orihuela, Barcelona, Laredo, Santander, Torrelavega, Ciudad Real
2026-04-22
Recruiting
Molecular Microbiology- Guided Antimicrobial Stewardship Versus Standard Stewardship in Hospitalized Patients
NCT07684300Infection, Antimicrobial Stewardship Program, Antimicrobial Resistance, Multiplex PCR
Maria Espinosa Perez
Not applicable
250
Elche
2026-04-10
Recruiting
LONG NAGOMI™ PMCF STUDY
NCT07399002Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
1,039
Cabueñes, Ciudad Real, Elche, Huelva, León, Málaga, Pamplona, Santander
2026-02-27
Recruiting
Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy
NCT07461220PARKINSON DISEASE (Disorder), Apathy, Safety
Integrative Research Laboratories AB
Phase 1/2
75
Barcelona, Elche, Madrid
2026-02-18
Recruiting
Laboratorios Ozoaqua
Not applicable
50
Elche
2026-02-06
Recruiting
Cardenal Herrera University
Observational
80
Elche
2026-01-25
Recruiting
Boehringer Ingelheim
Phase 3
400
Barcelona, Burgos, Elche, Jerez de la Frontera, Madrid, Majadahonda, Málaga, Pamplona
2026-01-16
Recruiting
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
NCT07222566Advanced Non-Small Cell Lung Cancer, Non-Small Cell Lung Cancer, Carcinoma, Non-Small-Cell Lung, Carcinoma, Non-Small-Cell Lung (NSCLC)
DrugsPF-08634404·Pembrolizumab
Pfizer
Phase 3
1,410
Santiago de Compostela, Elche, Granada, Seville, Barcelona, L'Hospitalet de Llobregat, Jerez de la Frontera, Girona
2026-01-06
Active, closed
SUSTAINA Study: Effects of Sustainable Diet and Therapeutic Exercise on Health in Young Athletes
NCT07567066Metabolic Health, Musculoskeletal Disorders (MSDs), Physical Fitness, Body Composition
University of Alicante
Not applicable
70
Elche
2026-01-01
Recruiting
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
NCT07218380Carcinoma, Transitional Cell, Urinary Bladder Neoplasms, Neoplasm Metastasis
DrugsVepugratinib·Pembrolizumab
Eli Lilly and Company
Phase 3
450
Badajoz, Badalona, Barakaldo, Barcelona, Córdoba, Elche, Girona, Hospitalet
2025-12-12
Recruiting
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
750
Barcelona, A Coruña, Alicante, Cabueñes, Cadiz, Elche, Getafe, Girona
2025-12-04
Recruiting
Zai Lab (Shanghai) Co., Ltd.
Phase 3
480
Valencia, Barcelona, Elche, Girona, Jerez de la Frontera, Madrid, Málaga, Pamplona
2025-11-30
Recruiting
Hoffmann-La Roche
Phase 3
900
Elche, Sant Cugat del Vallès, Donostia / San Sebastian, A Coruña, Alcorcón, Pozuelo de Alarcón, Barcelona, Madrid
2025-11-24
Recruiting
Cocreating Action to Improve Rationality in the Health System
NCT07237971Health-Related Quality-of-Life, Social Capital, Health Literacy, Community Based Participatory Research
Universidad Miguel Hernandez de Elche
Not applicable
4,000
Elche
2025-10-21
Recruiting
Grupo Español de Investigación en Diagnóstico y Tratamiento Hipertemprano de Enfermedades (GeDiTPhe)
Not applicable
1,200
Elche, Barcelona, Santander, Madrid, Oviedo, Toledo, Valencia
2025-10-08
Recruiting
Vertex Pharmaceuticals Incorporated
Phase 2/3
176
Barcelona, Córdoba, Elche, Lugo, Pamplona, Seville
2025-09-30
Recruiting
Bristol-Myers Squibb
Phase 2/3
600
A Coruña, Elche, Barcelona, Hospitalet, Donostia / San Sebastian, Madrid, Málaga, Valencia
2025-09-11
Recruiting
PALACE: Cemiplimab Trial According to ctDNA Levels
NCT06917573Non Small Cell Lung Cancer Metastatic, Lung Diseases, Stage IV Non-small Cell Lung Cancer, Stage III Non-small Cell Lung Cancer
DrugsCarboplatine·Cemiplimab·Paraplatin·Taxol
Fundación GECP
Phase 2
63
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Jerez de la Frontera, Girona
2025-07-29
Recruiting
Pfizer
Phase 3
714
A Coruña, Elche, Barcelona, L'Hospitalet de Llobregat, Jerez de la Frontera, Palma, Madrid, Valencia
2025-07-23
Recruiting
AstraZeneca
Phase 2
100
Barcelona, Elche, Madrid, Málaga, Ourense, Oviedo, Santander, Valencia
2025-07-17
Recruiting
MedSIR
Phase 2
20
Elche, Barcelona, Girona, Madrid, Reus, Alicante, Barakaldo, León
2025-06-27
Active, closed
University of Alicante
Not applicable
140
Elche
2025-06-01
Recruiting
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
NCT06901531Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Adrucil·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
500
Elche, San Cugat Del Valles Barcelona, Madrid, Navarra, A Coruña, Barcelona, El Palmar, Lleida
2025-05-22
Recruiting
Fundación EPIC
Observational
500
Albacete, Alicante, Badajoz, Castelló, Ciudad Real, Elche, L'Hospitalet de Llobregat, Laguna
2025-05-06
Recruiting
Hoffmann-La Roche
Phase 3
450
Elche, L'Hospitalet de Llobregat, Pamplona/iruña, Bilbao, Barcelona, Madrid, Málaga, Seville
2025-04-09
Recruiting
Universidad Miguel Hernandez de Elche
Not applicable
81
Elche
2025-03-28
Recruiting
Daiichi Sankyo
Phase 3
510
Burgos, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Ourense, Oviedo, Pamplona
2025-03-27
Active, closed
Fundacion para la Formacion e Investigacion Sanitarias de la Region de Murcia
Phase 4
120
Elche, Villajoyosa, Cartagena, Lorca, Murcia, Pozo-Aledo
2025-03-03
Recruiting
Daiichi Sankyo
Phase 3
726
Badalona, Barcelona, Córdoba, Elche, L'Hospitalet de Llobregat, Madrid, Málaga, Murcia
2025-02-27
Recruiting
Fundación GECP
Phase 3
129
Alicante, Elche, Badalona, Barcelona, L'Hospitalet de Llobregat, Bilbao, Jerez de la Frontera, A Coruña
2025-02-04
Not yet open
Parental Stress and Attachment in Preterm Infants
NCT06813560Premature Birth, Psychological Stress, Physiological Stress
Cardenal Herrera University
Observational
60
Elche
2025-02-01
Recruiting
Radiofrequency and Exercise-based Rehabilitation on Symptoms Associated With Pelvic Floor Dysfunctions in Breast Cancer
NCT06694519Breast Cancer, Genitourinary Syndrome, Radiofrequency, Physical Exercise
SERGIO MONTERO NAVARRO
Not applicable
117
Elche
2025-01-30
Active, closed
Pfizer
Phase 3
1,035
A Coruña, Elche, Seville, Barcelona, L'Hospitalet de Llobregat, Eixample, Bilbao, Jerez de la Frontera
2025-01-06
Recruiting
Hospital Universitario de Valme
Observational
9,000
Almería, Cadiz, Cartagena, Córdoba, Cuenca, Elche, Granada, Huelva
2025-01-01
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Barcelona, Elche, Girona, Madrid, Pamplona, Vigo, Zaragoza
2024-12-13
Recruiting
Novartis Pharmaceuticals
Phase 3
60
Elche, Cadiz, Badalona, Esplugues, Pamplona, Barcelona, Málaga, Seville
2024-12-09
Recruiting
Merck Sharp & Dohme LLC
Phase 3
3,082
Elche, Badalona, Centelles, Barcelona, A Coruña, Cartagena, Madrid, Seville
2024-12-02
Recruiting
Aerobic Exercise-induced Effect on Endothelial Function in Patients With Ischaemic Heart Disease
NCT06788275Percutaneous Coronary Intervention (PCI), Acute Myocardial Infarction, Angina (Stable), Unstable Angina Pectoris
Instituto de Investigación Sanitaria y Biomédica de Alicante
Not applicable
132
Alicante, Elche
2024-11-01
Active, closed
Teva Branded Pharmaceutical Products R&D LLC
Phase 2
349
Barakaldo, Barcelona, Elche, Madrid, Pamplona, Seville, Valencia
2024-10-02
Recruiting
Instituto de Investigación Sanitaria y Biomédica de Alicante
Phase 3
42
Alicante, Elche
2024-10-01
Active, closed
Universidad Miguel Hernandez de Elche
Not applicable
184
Elche
2024-09-09
Recruiting
Jazz Pharmaceuticals
Phase 3
550
A Coruña, Badajoz, Barcelona, Elche, Granada, Madrid, San Cristóbal de La Laguna, Seville
2024-08-13
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
982
Barcelona, Elche, Girona, Granada, Jaén, León, Madrid, Majadahonda
2024-07-31
Recruiting
NovoCure GmbH
Phase 3
734
Elche, Seville, Barcelona, Torrejón de Ardoz, Lleida, Madrid, Málaga, Pamplona
2024-07-31
Active, closed
Regeneron Pharmaceuticals
Phase 2
195
Santiago de Compostela, Elche, Granada, Palma, Barcelona, Majadahonda, El Palmar, Pamplona
2024-07-16
Recruiting
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Observational
40
Elche
2024-07-09
Not yet open
Management of Early-onset Fetal Growth Restriction: Angiogenic Factors Versus Feto-placental Doppler
NCT05284474Fetal Growth Retardation, Preeclampsia, Placenta Diseases
Hospital Universitari Vall d'Hebron Research Institute
Not applicable
340
A Coruña, Alicante, Badalona, Barcelona, Cadiz, Elche, Getafe, Gijón
2024-06-03
Recruiting
Hyperangulated vs Macintosh Blades for Intubation With Videolaryngoscopy in ICU
NCT06322719Acute Respiratory Failure, Intubation, Intubation; Difficult or Failed, Videolaryngoscopy
Hospital Clinico Universitario de Santiago
Not applicable
1,036
Santiago de Compostela, A Coruña, Albacete, Barcelona, Cáceres, Denia, Elche, Gijón
2024-05-01
Recruiting
Integrated Approach in Frail Older People with Atrial Fibrillation
NCT06775028Atrial Fibrillation (AF), Hypertension, Coronary Arterial Disease (CAD), Heart Failure
Heart Care Foundation
Not applicable
1,250
Alicante, Cartagena, Cártama, Elche, Málaga, Murcia, Sant Joan d'Alacant, Tarragona
2024-04-11
Active, closed
MedSIR
Phase 2
976
A Coruña, Alicante, Barcelona, Bilbao, Castellon, Córdoba, Elche, Girona
2024-04-01
Recruiting
Hospital Universitario La Fe
Not applicable
1,272
Huelva, Valencia, A Coruña, Burgos, Castelló, Córdoba, Elche, Granada
2024-03-11
Recruiting
Study of Olverembatinib (HQP1351) in Patients With CML-CP
NCT06423911Chronic Myeloid Leukemia, CML, CML, Chronic Phase
DrugsBosutinib·Olverembatinib
Ascentage Pharma Group Inc.
Phase 3
333
Badalona, Barcelona, Elche, L'Hospitalet de Llobregat, Madrid, Majadahonda, Málaga, Murcia
2024-02-05
Active, closed
AbbVie
Observational
427
Santiago de Compostela, Elche, Majadahonda, Granada, Madrid, Seville
2024-01-24
Active, closed
Effectiveness of the Universal Prevention Program Super Skills for Life in Schools
NCT06444581Social Skills, Perfectionism, Self Esteem, Positive Affect
Universidad Miguel Hernandez de Elche
Not applicable
1,100
Elche
2024-01-08
Recruiting
Cardenal Herrera University
Not applicable
30
Elche
2023-11-30
By invitation
University of California, Santa Barbara
Not applicable
7
Elche
2023-10-02
Active, closed
OncoC4, Inc.
Phase 3
630
Elche, Lugo, Madrid, Málaga, Valencia
2023-06-28
Recruiting
SUPRAFLEX CRUZ PMCF Study ( rEpic05 )
NCT05617599Coronary Artery Disease (CAD), Ischemic Heart Disease
Fundación EPIC
Observational
508
Elche, A Coruña, Barakaldo, Barcelona, Castelló, Cáceres, Ciudad Real, Girona
2023-05-10
Active, closed
Gilead Sciences
Phase 3
654
Barcelona, Bilbao, Córdoba, Elche, Jaén, Madrid, Salamanca, Santiago de Compostela
2023-05-08
Active, closed
Servier Affaires Médicales
Phase 3
299
A Coruña, Barcelona, Córdoba, Elche, Madrid, Pamplona, Santander
2023-05-03
Recruiting
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120Heart Diseases, Coronary Artery Disease, Coronary Artery Bypass Grafting
Weill Medical College of Cornell University
Not applicable
2,300
Elche, Barcelona, Madrid, Pamplona
2023-04-17
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
DrugInclisiran
Novartis Pharmaceuticals
Phase 3
14,012
Ferrol, Santiago, Santiago Compostela, Elche, Granada, Huelva, Marbella, Málaga
2023-03-09
Active, closed
Merck Sharp & Dohme LLC
Phase 3
537
Elche, Badalona, Barcelona, L'Hospitalet de Llobregat,Barcelona, Madrid, Málaga
2023-03-08
Active, closed
Pfizer
Phase 3
624
A Coruña, Elche, Badalona, Barcelona, Bilbao, L'Hospitalet de Llobregat, Donostia / San Sebastian, Lleida
2023-03-03
Active, closed
Novartis Pharmaceuticals
Phase 3
436
Santiago Compostela, Elche, Badalona, Santander, Barcelona, San Sebastian Reyes, Pamplona, Vigo
2023-03-02
Active, closed
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant Neratinib
NCT05252988Early-stage Breast Cancer, HER2 Positive Breast Cancer, Hormone Receptor Positive
DrugsColesevelam·Loperamide·Neratinib
Spanish Breast Cancer Research Group
Phase 2
177
Elche, Málaga, Zaragoza, L'Hospitalet de Llobregat, Manresa, Mataró, Castellon, Valladolid
2022-08-31
Active, closed
EMD Serono Research & Development Institute, Inc.
Phase 2
256
Badajoz, Barcelona, Córdoba, Elche, Lugo, Madrid, Manresa
2022-08-17
Active, closed
ARCAGY/ GINECO GROUP
Phase 3
260
Elche, Badalona, Córdoba, León, Palma, Palma de Mallorca, Santiago de Compostela, Valencia
2022-04-15
Recruiting
Hospital Universitario de Fuenlabrada
Phase 4
216
Elche, Almería, Badajoz, Sant Joan Despí, Castellon, Ciudad Real, Córdoba, San Sebastián
2022-03-02
Recruiting
Hospital General Universitario de Alicante
Phase 3
332
Santiago de Compostela, Alicante, Elche, Barcelona, L'Hospitalet de Llobregat, Sabadell, Santander, Granada
2021-11-10
Active, closed
Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice
NCT04899141Coronary Artery Disease, Ischemic Heart Disease
Fundación EPIC
Observational
400
Málaga, Barakaldo, Barcelona, Cáceres, Ciudad Real, Donostia / San Sebastian, Elche, Galdakao
2021-10-29
Active, closed
Camurus AB
Phase 3
332
A Coruña, Barcelona, Elche, Girona, Madrid, Málaga, Murcia, Oviedo
2021-10-22
Active, closed
Merck Sharp & Dohme LLC
Phase 3
2,000
Elche, Badalona, Barcelona, Madrid
2021-09-15
Active, closed
Hoffmann-La Roche
Phase 3
4,170
Elche, Palma de Mallorca, Badalona, Manresa, Sabadell, Santiago de Compostela, Jerez de la Frontera, Castellon de LA Plana/castello de LA Plana
2021-08-27
Recruiting
Valved Graft PMCF Study
NCT04754217Aortic Valve Disease, Ascending Aorta Abnormality, Aortic Dissection
Abbott Medical Devices
Observational
260
Elche, Palma de Mallorca
2021-07-13
Active, closed
Pfizer
Phase 3
599
Elche, Badalona, L'Hospitalet de Llobregat, Manresa, Lugo, Majadahonda, Pamplona, Oviedo
2021-05-12
Active, closed
Hoffmann-La Roche
Phase 2
586
Elche, Sant Cugat del Vallès, Donosti-San Sebastián, A Coruña, Alcorcón, Móstoles, Pozuelo de Alarcón, Pamplona
2021-05-05
Active, closed
Hoffmann-La Roche
Phase 3
1,188
Elche, Badalona, Sabadell, Jerez de la Frontera, Vigo, San Cristóbal de La Laguna, Bilbao, Granada
2021-05-04
Recruiting
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
NCT04657068Advanced Cancer, Metastatic Cancer, Ovarian Cancer, Primary Peritoneal Cancer
DrugsIrinotecan·Gemcitabine
Artios Pharma Ltd
Phase 1/2
542
Elche, Sabadell, Santander, Barcelona, Lleida, Madrid, Pozuelo de Alarcón, El Palmar
2021-01-27
Active, closed
Pfizer
Phase 3
841
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Barcelona, Madrid, Seville, Valencia, Zaragoza
2020-12-21
Active, closed
Bayer
Phase 3
402
Elche, Manacor, Palma de Mallorca, Sabadell, Alcorcón, Barcelona, Cáceres, Córdoba
2020-10-20
Active, closed
Exelixis
Phase 3
575
Elche, Palma de Mallorca, Manresa, Santiago de Compostela, Alcorcón, Oviedo, Badalona, Barcelona
2020-10-19
Recruiting
Efficacy and Safety Evaluation for the Treatment of Allergy Against Mites
NCT04435990Rhinitis, Allergic, Rhinoconjunctivitis, Asthma, Allergic
Inmunotek S.L.
Phase 3
150
Santiago de Compostela, Elche, Torrevieja, Valencia, Algeciras, Jerez de la Frontera, Cartagena, Vigo
2020-10-06
Active, closed
Women's Cancer Study Group GmbH
Phase 3
1,260
Palma, Barcelona, Cáceres, Elche, Madrid, Manresa, Málaga, Pamplona
2020-09-02
Recruiting
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
NCT04389632Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, HER2 Negative Breast Neoplasms, Esophageal Squamous Cell Carcinoma
DrugsSigvotatug vedotin·Keytruda·Cisplatin·Carboplatin
Seagen, a wholly owned subsidiary of Pfizer
Phase 1
1,006
Madrid, Elche, Santander, Barcelona, Jerez de la Frontera, Málaga
2020-06-08
Recruiting
Spanish Registry of Esophagogastric Cancer
NCT04958720Esophageal Cancer, Gastric Cancer
Fundación Sociedad Española de Oncologia Médica
Observational
10,000
Alicante, Elche, Elda, Córdoba, Málaga, Seville, Palma de Mallorca, Barcelona
2020-04-27
Recruiting
Universidad Miguel Hernandez de Elche
Not applicable
5
Elche
2019-10-01
Active, closed
Grupo Español de Investigación en Cáncer de Ovario
Phase 2
134
Elche, Donostia / San Sebastian, Girona, Madrid, Vigo, Seville, Valencia, Barcelona
2019-06-28
Active, closed
Novartis Pharmaceuticals
Phase 3
5,101
Elche, Granada, Huelva, Jaén, Vitoria-Gasteiz, Badalona, L'Hospitalet de Llobregat, Manresa
2018-12-07
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
DrugsZolbetuximab·Capecitabine·Oxaliplatin
Astellas Pharma Global Development, Inc.
Phase 3
507
A Coruña, Barcelona, Elche, Madrid, Málaga, Pamplona, Valencia
2018-11-28
Recruiting
Xynomic Pharmaceuticals, Inc.
Phase 3
413
Elche, Madrid, Málaga
2018-07-17
Recruiting
Fundación Sociedad Española de Oncologia Médica
Observational
700
Alcoy, Elche, Palma, L'Hospitalet de Llobregat, Sabadell, Sant Joan Despí, Santander, Jerez de la Frontera
2018-07-04
Active, closed
Pfizer
Phase 3
1,054
Santiago de Compostela, Elche, L'Hospitalet de Llobregat, Sabadell, El Palmar, Barcelona, Madrid
2017-12-18
Active, closed
Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors
NCT03170960Urothelial Carcinoma, Renal Cell Carcinoma, Non-Small Cell Lung Cancer, Castration-resistant Prostate Cancer
DrugsCabozantinib·Tecentriq·Atezolizumab
Exelixis
Phase 1
914
Santiago de Compostela, Elche, Palma de Mallorca, Badalona, Sabadell, Jeréz de La Frontera, Pamplona, Oviedo
2017-09-05
Recruiting
European Organisation for Research and Treatment of Cancer - EORTC
Observational
4,975
L'Hospitalet de Llobregat, Barcelona, Elche, Girona, Madrid, Málaga, Valencia, Valladolid
2017-05-03
Recruiting
Organ Preservation in Locally Advanced Rectal Cancer
NCT03064646LOCALLY ADVANCED RECTAL CANCER
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
Not applicable
30
Elche
2017-03-10
Recruiting
Spanish Breast Cancer Research Group
Observational
1,867
Elche, Manresa, Terrassa, San Sebastián, Las Palmas de Gran Canaria, Alcorcón, Fuenlabrada, Leganés
2016-08
Recruiting
Thoracic Tumours Register
NCT02941458Thoracic Tumors
Spanish Lung Cancer Group
Observational
10,000
Ferrol, Albacete, Alcoy, Alicante, Elche, Elda, Badalona, Barcelona
2016-07-21
Active, closed
AstraZeneca
Phase 3
682
A Coruña, Barcelona, Donostia / San Sebastian, Elche, Las Palmas de Gran Canaria, Madrid, Majadahonda, Málaga
2015-10-21
Active, closed
Eli Lilly and Company
Phase 3
669
Elche, Barcelona, Lleida, Madrid, Murcia, Valencia
2014-07-22
Active, closed
AbbVie
Observational
8,250
A Coruña, Ferrol, Santiago de Compostela, Elche, Sant Joan d'Alacant, Manacor, Palma de Mallorca, Badalona
2013-04-29
Recruiting
Product Surveillance Registry
NCT01524276Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
A Coruña, Córdoba, Elche, Girona, Granada, L'Hospitalet de Llobregat, Madrid, Málaga
2012-01
Active, closed
Genentech, Inc.
Phase 2
378
Elche, Jerez de la Frontera, Donostia / San Sebastian, Barcelona, Cáceres, Lleida, Madrid, Zaragoza
2008-10-16
Recruiting
Manuel Monreal
Observational
120,000
A Coruña, Cee, Ferrol, Ribeira, Santiago de Compostela, Albacete, Alicante, Elche
2001-03
Rows per page Showing 1–111 of 111
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Spanish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 12 October 2026. https://priyalifescience.com/clinical-trials-spain/city/elche

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Spain and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,875 studies in total at the last sync on 11 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 111 of those studies with a site in Elche.

How many clinical trials are recruiting in Elche?

64 of the 111 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:18 UTC sync. A further 4 have not yet opened recruitment, 42 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Elche), 111 studies
PhaseStudiesRecruitingShare
Phase 3462141.4%
Not applicable241721.6%
Observational191517.1%
Phase 213411.7%
Phase 4322.7%
Phase 1211.8%
Phase 1/2221.8%
Phase 2/3221.8%

Most active sponsors

Lead sponsors with the most studies (Elche)
Lead sponsorStudiesRecruiting
Pfizer72
Universidad Miguel Hernandez de Elche63
Hoffmann-La Roche52
Fundación EPIC43
Fundación GECP43
Novartis Pharmaceuticals41
Astellas Pharma Global Development, Inc.31
Cardenal Herrera University32
Merck Sharp & Dohme LLC31
University of Alicante31
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.